Vivanza Biosciences Profit & Loss Annual

BSE: 530057 | NSE: - | ISIN: INE984E01035 | Sector: Biotechnology & Drugs

2.35 -0.06 (-2.49%)Updated : 13 Jun 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Revenue	7.42	27.84	17.81	10.40
Total Revenue	7.42	27.84	17.81	10.40
Costof Revenue Total	6.82	25.95	16.51	9.65
Gross Profit	0.60	1.88	1.30	0.75
Selling/ General/ Admin Expenses Total	0.58	0.45	0.35	0.30
Depreciation/ Amortization	0.01	0.01	0.00	0.01
Other Operating Expenses Total	0.39	0.37	0.29	0.53
Total Operating Expense	7.80	26.78	17.15	10.49
Operating Income	-0.38	1.05	0.66	-0.09
Interest Inc( Exp) Net- Non- Op Total	-0.35	-0.41	-0.42	-0.41
Other Net	0.06	0.05	0.48	0.83
Net Income Before Taxes	-0.67	0.70	0.72	0.33
Provisionfor Income Taxes	0.01	0.15	0.12	0.00
Net Income After Taxes	-0.67	0.55	0.60	0.33
Net Income Before Extra Items	-0.67	0.55	0.60	0.33
Net Income	-0.67	0.55	0.60	0.33
Income Availableto Com Excl Extra Ord	-0.67	0.55	0.60	0.33
Income Availableto Com Incl Extra Ord	-0.67	0.55	0.60	0.33
Diluted Net Income	-0.67	0.55	0.60	0.33
Diluted Weighted Average Shares	4.00	3.91	4.00	4.00
Diluted EPS Excluding Extra Ord Items	-0.17	0.14	0.15	0.08
Diluted Normalized EPS	-0.17	0.14	0.15	0.08
period Length	12.00	12.00	12.00	12.00
period Type	-	-	-	-
Unusual Expense( Income)	-	-	0.00	0.00
Total Adjustmentsto Net Income	-	-	0.00	-